Use of serotonin (5-hydroxytryptamine) reuptake inhibitors in the treatment of alcoholism.

@article{Lejoyeux1996UseOS,
  title={Use of serotonin (5-hydroxytryptamine) reuptake inhibitors in the treatment of alcoholism.},
  author={M. Lejoyeux},
  journal={Alcohol and alcoholism (Oxford, Oxfordshire). Supplement},
  year={1996},
  volume={31 1},
  pages={
          69-75
        }
}
  • M. Lejoyeux
  • Published 1996
  • Medicine
  • Alcohol and alcoholism (Oxford, Oxfordshire). Supplement
Animal studies have shown that alcohol consumption is reduced when serotonin (5-hydroxytryptamine, 5-HT) levels are increased in the central nervous system. Similarly, studies of alcohol-dependent human subjects have shown that treatment with 5-HT reuptake inhibitors (i.e. zimeldine, citalopram, fluoxetine, and fluvoxamine) decreases the desire to drink alcohol and improves symptoms of alcohol-related anxiety and depression in patients who have undergone detoxification. However, not all studies… Expand
The status of serotonin-selective pharmacotherapy in the treatment of alcohol dependence.
  • H. Pettinati, H. Kranzler, J. Madaras
  • Medicine
  • Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism
  • 2003
TLDR
This chapter will discuss the usefulness of 5-HT-selective pharmacotherapy in treating alcohol dependence and will provide both historical and current perspectives on its use. Expand
The use of selective serotonin reuptake inhibitors in treating alcoholic subtypes.
  • H. Pettinati
  • Medicine, Psychology
  • The Journal of clinical psychiatry
  • 2001
TLDR
Results thus far indicate that alcoholic subgroups are differentially responsive to 5-HT pharmacotherapy with respect to drinking-related outcomes, and there are preliminary results encouraging the use of SSRIs in combination with other medications for treating alcohol dependence in patients with and without comorbid psychiatric disorders. Expand
Role of Serotonin and Serotonin-Selective Pharmacotherapy in Alcohol Dependence
TLDR
There is growing evidence to suggest that alcohol-dependent subgroups are differentially responsive to 5-HT pharmacotherapies with respect to drinking-related outcomes. Expand
Polymorphism of the Serotonin Transporter
TLDR
Clinical effects of the polymorphisms may be associated with effects on platelets, neural 5-HTT levels, and indices of serotonergic function, and potential confounding factors include age, gender, and population stratification. Expand
Serotonin transporter gene polymorphisms in alcohol dependence.
TLDR
The data presented suggests a trend toward increased frequency of the S promoter allele in alcohol-dependent, alcoholic-TS and TS patients. Expand
Alcohol Dependence and Withdrawal Impair Serotonergic Regulation of GABA Transmission in the Rat Central Nucleus of the Amygdala
TLDR
Examination of neuroadaptations of CeA 5-HT signaling in adult, male Sprague Dawley rats using an established model of alcohol dependence, ex vivo electrophysiology and ISH provides mechanistic insights into how both chronic alcohol exposure and protracted withdrawal dysregulate 5- HT signaling in the CeA. Expand
Antidepressants attenuate both the enhanced ethanol intake and ethanol-induced anxiolytic effects in diazepam withdrawn rats
TLDR
It is suggested that desipramine and fluoxetine could be effective pharmacological tools to prevent the subsequent development of ethanol dependence in rats previously exposed to DZM withdrawal. Expand
Effects of acute and chronic treatment with fluoxetine on regional glucose cerebral metabolism in rats: implications for clinical therapies
TLDR
The findings suggest that fluoxetine may be therapeutic by increasing the 5-HT-negative modulation upon areas that drive the abnormally hyperactive responses to stress found in several neuropsychiatric conditions. Expand
Alcohol intake after serotonin transporter inactivation in mice.
TLDR
Knock-out mice lacking the serotonin transporter [5-hydroxytryptamine transporter (5-HTT)] were used to assess the influence of 5-HT re-uptake on ethanol consumption, and pharmacological blockade of5- HTT by fluoxetine reduced alcohol intake in wild-type mice only. Expand
Effects of venlafaxine on ethanol withdrawal syndrome in rats
TLDR
It is suggested that acute venlafaxine treatment has limited beneficial effects on ethanol withdrawal syndrome in rats and that a two‐way anova of the data did not indicate any significant effect. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 42 REFERENCES
Serotonin uptake inhibitors attenuate ethanol intake in problem drinkers.
  • C. Naranjo, E. Sellers
  • Medicine
  • Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism
  • 1989
TLDR
Serotonin uptake inhibitors suggest an innovative approach for moderating ethanol intake in problem drinkers through attenuation of alcohol intake via serotonin uptake inhibitors, which is distinct from the antidepressant properties of these drugs. Expand
The serotonin uptake inhibitor citalopram attenuates ethanol intake
TLDR
Citalopram, a selective serotonin uptake inhibitor, decreased the number of drinks consumed and increased the numbers of abstinent days in male nondepressed early‐stage problem drinkers and is probably through modulation of the neurobiologic mechanisms regulating ethanol intake. Expand
Fluoxetine trial in suicidal depressed alcoholics.
TLDR
It is suggested that fluoxetine has potential for treating the depressive symptoms and the excessive alcohol intake of depressed alcoholics. Expand
Tricyclic antidepressants in the treatment of alcoholism and drug abuse.
TLDR
Although imipramine has shown only equivocal success in the treatment of alcoholics, preliminary studies of serotonin uptake inhibitors show some promise in this population, and future studies may more clearly identify subgroups of chemically dependent patients who respond to specific antidepressant drugs. Expand
Platelet serotonin levels in alcoholic patients: Changes related to physiological and pathological factors
TLDR
In patients, platelet 5-HT levels during withdrawal from alcohol and after 2 weeks of abstinence were significantly lower than in control subjects, and this decrease was enhanced both in alcohol-dependent patients and in patients who were depressed during the withdrawal phase. Expand
Use of serotonin-active drugs in alcohol preference studies.
  • J. E. Zabik
  • Medicine
  • Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism
  • 1989
TLDR
The intent of research reviewed here has been a better understanding of the role that brain serotonergic function may play in the regulation of ethanol ingestion and insight into the complexity of alcoholism. Expand
Buspirone in the treatment of alcoholic patients.
  • F. Bruno
  • Psychology, Medicine
  • Psychopathology
  • 1989
TLDR
The findings suggest that further evaluation of buspirone in the management of alcoholism, especially abstinent alcoholics, is warranted, and should be interpreted with caution due to the limited sample size and high placebo discontinuation rate. Expand
Platelet affinity for serotonin is increased in alcoholics and former alcoholics: a biological marker for dependence?
TLDR
It is believed that this increased platelet affinity for serotonin, in the absence of cirrhosis of the liver and/or depression could be a marker for alcohol dependence, enabling the therapeutic effort to be focussed on patients. Expand
Zimelidine‐induced variations in alcohol intake by nondepressed heavy drinkers
TLDR
The data suggest that zimelidine modifies alcohol intake by a different mechanism than previously tested drugs, possibly by modulating the central neural mechanism that controls drinking of alcohol. Expand
Effect of citalopram on alcohol intake in heavy drinkers.
TLDR
Citalopram at the present dose appears capable of reducing alcohol intake only in a subgroup of heavy drinkers with a mean daily consumption of between 60 and 100 g pure alcohol. Expand
...
1
2
3
4
5
...